Altered proximal aortic stiffness and endothelin plasma levels in diabetic patients with end-stage renal disease

ASAIO Journal

Volumn 53, Issue 3, 2007, Pages 343-350

  Karakitsos, Dimitrios ^a,b   Patrianakos, Alexandros P ^a   Parthenakis, Frangiskos I ^a   Malliaraki, Niki ^a   Nikitovic, Draguena ^a   Kyriazis, John ^c   Karabinis, Andreas ^b   Groothoff, Jaap W ^d   De Groot, Eric ^d   Fourtounas, Costas ^e   Daphnis, Eugene ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

^c General Hospital of Chios   (Greece)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; DISEASES; MEDICAL IMAGING; MEDICAL PROBLEMS; PATIENT TREATMENT; PROTEINS; ULTRASONICS;

PERIPHERAL ARTERY STIFFNESS; PLASMA ENDOTHELIN LEVELS; PROXIMAL AORTIC STIFFNESS; ULTRASOUND IMAGING;

PLASMA (HUMAN);

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PHOSPHATE BINDING AGENT; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGE DISTRIBUTION; AORTA; ARTERY TONE; ARTICLE; BODY SURFACE; CONTROLLED STUDY; DIALYSIS; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE; HEART VENTRICLE SIZE; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY FAILURE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PULSE PRESSURE; PULSE WAVE; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; ULTRASOUND;

AGED; AORTIC DISEASES; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; DIABETIC ANGIOPATHIES; ECHOCARDIOGRAPHY; ENDOTHELIN-1; FEMALE; HOMOCYSTEINE; HUMANS; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULSATILE FLOW; TRIGLYCERIDES;

EID: 34249059272     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e318050d607     Document Type: Article

References (42)

1. Brunner FP, Selwood NH: Profile of patients on RRT in Europe and death rates due to major causes of death groups: the EDTA registration committee. Kidney Int Suppl 38: 4-15, 1992.
2. Lindner A, Charra B, Sherrard D, Scribner BM: Accelerated atherosclerosis in prolonged maintenance hemodialysis, N Engl J Med 290: 697-702, 1974.
3. London GM, Guerin AP, Marchais SJ, et al: Cardiac and arterial interactions in end stage renal disease. Kidney Int 50: 600-608, 1996.
4. Shoji T, Emoto M, Shinohara K, et al: Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 12: 2117-2124, 2001.
5. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103: 987-992, 2001.
6. Pastan S, Bailey J: Dialysis therapy. N Engl J Med 338: 1428-1437, 1998.
7. Johnson JG, Gore SM, Firth J: The effect of age, diabetes, and other co morbidity on the survival of patients on dialysis: a systematic quantitative overview of the literature. Nephrol Dial Transplant 14: 2156-2164, 1999.
8. Schram MT, Henry RMA, Van Dijk RA: JM, et al: Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn study. Hypertension 43: 176-181, 2004.
9. Patrianakos A, Karakitsos D, De Groot E, Parthenakis F, Daphnis E, Vardas P: Alteration of the proximal aorta biophysical properties in patients with end-stage renal disease. Heart 92: 228-232, 2006.
10. Nishimura M, Hashimoto T, Kobayashi H, et al: Different remodelling against left ventricular overload between diabetic and non-diabetic haemodialysis patients. Clin Exp Pharmacol Physiol 10: 786-792, 2003.
11. Hocher B, Ziebig R, Altermann C, et al: Different impact of biomarkers as mortality predictors among diabetic and nondiabetic patients undergoing hemodialysis. J Am Soc Nephrol 14: 2329-2337, 2003.
12. Demuth K, Blacher J, Guerin AP, et al: Endothelin and cardiovascular remodelling in end-stage renal disease. Nephrol Dial Transplant 13: 375-383, 1998.
13. Kim BS, Jeon DS, Shin MJ, et al: Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis, Am J Nephrol 25: 189-195, 2005.
14. Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM: Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease, Arterioscler Thromb Vasc Biol 18: 535-541, 1998.
15. Karakitsos D, De Groot E, Patrianakos AP, et al: Adiponectin and cardiovascular remodeling in end-stage renal disease and comorbid diabetes mellitus. Am J Nephrol 5: 340-347, 2006.
16. Schiller NB, Shah PM, Crawford M, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2: 358-367, 1989.
17. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 55: 613-618, 1977.
18. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG: Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 106: 2085-2090, 2002.
19. Fortin LJ, Genest J: Measurement of homocysteine in the prediction of atherosclerosis. Clin Biochem 28: 155-162, 1995.
20. Slowinski T, Neumayer HH, Stolze T, Gossing G, Halle H, Hocher B: Endothelin system in normal and hypertensive pregnancy. Clin Sci 103: 446-449, 2002.
21. Gosling RG, Budge MM: Terminology for describing the elastic behavior of arteries. Hypertension 41: 1180-1182, 2003.
22. Nichols WW, O'Rourke MF: Vascular impedance, in McDonald's blood flow in arteries: theoretical, experimental and clinical principles, (1998) 4th ed. Edward Arnold, London.
23. Frank O: Die Theorie de Pulswellen. Ztschr Biol 85: 91-130, 1926.
24. Marchais SJ, Guerin A, Pannier BM, Levy BI, Safar ME, London GM: Wave reflections and cardiac hypertrophy in chronic uremia. Hypertension 22: 876-883, 1993.
25. Benetos A, Waeber B, Izzo J, et al: Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 15: 1101-1108, 2002.
26. Rahn KH, Barenbrock M, Hausberg M, Kosch M, Suwelack B, Witta J: Vessel wall alterations in patients with renal failure. Hypertens Res 23: 3-6, 2000.
27. Hishikawa X, Nakati T, Marumo T, Suzuki H, Kato, R, Saruta T: Pressure enhances endothelin-1 release from cultured human endothelial cells. Hypertension 25: 449-452, 1995.
28. McEniery CM, Qasem A, Schmidtt M, Avolio A, Cockroft JR, Wilkinson IB: Endothelin-1 regulates arterial pulse wave velocity in vivo. J Am Coll Cardiol 42: 1975-1981, 2003.
29. Vane JR, Anggard EE, Botting RM: Mechanisms of disease: regulatory functions of the vascular endothelium. N Engl J Med 323: 27-36, 1990.
30. Kimoto E, Shoji T, Shinohara K, et al: Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes 52: 448-452, 2003.
31. Wittekoek ME, de Groot E, Prins MH, Trip MD, Buller HR, Kastelein JJ: Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease. Atherosclerosis 146: 271-279, 1999.
32. Tsuchiya M, Suzuki E, Egawa K, et al: Abnormal peripheral circulation in type 2 diabetic patients with normal ankle-brachial index associates with coronary atherosclerosis, large artery stiffness, and peripheral vascular resistance. Diabetes Res Clin Pract 70: 253-262, 2005.
33. Cameron JD, Bulpitt CJ, Pinto ES, Rajkumar C: The aging of elastic and muscular arteries: a comparison of diabetic and nondiabetic subjects. Diabetes Care 26: 2133-2138, 2003.
34. Taniwaki H, Kawagishi T, Emoto M, et al: Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes: vessel wall properties in type 2 diabetes. Diabetes Care 22: 1851-1857, 1999.
35. Rask-Madsen C, King GL: Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler Thromb Vasc Biol 25: 487-96, 2005.
36. Oishi K, Nagake Y, Yamasaki H, et al: The significance of serum homocysteine levels in diabetic patients on haemodialysis. Nephrol Dial Transplant 15: 851-855, 2000.
37. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263: 2893-2898, 1990.
38. Henry RM, Kostense PJ, Spijkerman AM, et al: Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 107: 2089-2095, 2003.
39. Makita Z, Bucala R, Rayfield EJ, et al: Reactive glycosylation end products in diabetic uremia and treatment of renal failure: Lancet 18: 1519-1522, 1994.
40. Cantini C, Kieffer P, Corman B, Liminana P, Atkinson J, Lartaud-Idjouadiene I: Aminoguanidine and aortic wall mechanics, structure, and composition in aged rats. Hypertension 38: 943-948, 2001.
41. Kass DA, Shapiro EP, Kawaguchi M, et al: Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 104: 1464-1470, 2001.
42. Goodfriend TL: Aldosterone: a hormone of cardiovascular adaptation and maladaptation. J Clin Hypertens 8: 133-139, 2006.